Mammalian expression and T7 in vitro transcription dual ussage vector of SARS-CoV-2 ORF1a (nsp1 deltaGlu 155-His165: ribosome binding site for disrupting regular translation).
Clone info. | Mammalian expression and T7 in vitro transcription dual ussage vector of SARS-CoV-2 ORF1a (nsp1 deltaGlu 155-His165: ribosome binding site for disrupting regular translation). Corresponding NC_045512.2: 266..13483, Bacterial low copy number plasmid. |
---|---|
Comment | Delivative of pMWT7-KpnI-polyA (RDB19684). |
Vector backbone | pMWcmvT7-KpnI-polyA (RDB19684) (plasmid) |
Growth conditions | LB+km, 23℃ |
Gene/insert name | SARS-CoV-2 ORF1a |
Depositor|Developer | DNA Bank, | Nakashima, Kenichi | |
Sequence (full) | RDB20253hts01.seq ![]() |
---|---|
Publication | Unpublished bioresource |
Test sheet | RDB20253C0p1-1.pdf ![]() |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment ![]() ![]() ![]() MTA, for use for not-for-profit academic purpose [Word ![]() ![]() Please visit Information of Request for Distribution.[link] For for-profit-research purpose, please contact us. |
---|---|
Terms and conditions for distribution | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to DEPOSITOR and a citation of the literature designated by the DEPOSITOR are requested. () |
必要書類 | 提供依頼書 ![]() ![]() 提供同意書 (MTA, 非営利学術目的用)[Word ![]() ![]() 手続きの概要は、「提供申込みについて[link]」をご覧ください。営利目的利用についてはお問い合わせください。 |
---|---|
MTAに書く使用条件 | 利用者は、研究成果の公表にあたって寄託者の指定する文献を引用すること(決定次第、理研BRCで記載する)。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB20253 | pMWcmvT7-ORF1a(nsp1deltaRB)-pA | DNA solution |
Materials & Methods section:
The pMWcmvT7-ORF1a(nsp1deltaRB)-pA was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB20253). |
Reference section:
Further references such as user reports and related articles (go to bottom)
Original, user report and related articles
Featured content